Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial testing Rituximab plus Beta-Glucan in chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial of thalidomide with or without fludarabine in patients with small lymphocytic lymphoma and chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma [Phase 1]
Phase 1 study evaluating a combination of alvocidib, fludarabine phosphate, and rituximab in various B-cell lymphoproliferative disorders, w…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of a monoclonal antibody therapy in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, acute lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating a monoclonal antibody in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lympho…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis [Phase 2]
Phase 2 study update analyzing DNA microarray gene expression in chronic lymphocytic leukemia and small lymphocytic lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating preemptive immunointervention after allogeneic hematopoietic stem ce…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [NA]
A clinical trial evaluated arsenic trioxide in patients with relapsed or refractory lymphoma and leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This update reports the completion of a Phase 2 trial of perifosine in relapsed or refractory chronic lymphocytic leukemia and small lymphoc…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma [Phase 2]
A Phase 2 trial investigating 506U78 in patients with recurrent or refractory non-Hodgkin's lymphoma and T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating thalidomide in relapsed or refractory non-Hodgkin lymphoma has completed enrollment. The study included patients wi…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 study of EL625 in patients with persistent chronic lymphocytic leukemia or small lymphocytic lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial investigating rituximab, pentostatin, cyclophosphamide, and lenalidomide in previously untreated B-cell chronic lymph…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies [Phase 2]
Phase II study assessing AT-101 as a single-agent therapy in relapsed or refractory B-cell malignancies has completed, reporting safety and …
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide for relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma …
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating oblimersen sodium in combination with rituximab for recurrent B-cell non-Hodgkin lymphoma completed, with results…
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating Rituximab and Fludarabine followed by alemtuzumab (CAMPATH-1H) in chronic lymphocytic leukemia and small lymphocyti…
-
CLINICAL_TRIALS trial_result · 2008-09-11Clinical Trial Update: Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1, Phase 2]
Phase 1/2 study of weekly motexafin gadolinium (Xcytrin) in chronic lymphocytic leukemia and small lymphocytic lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia [Phase 1]
This clinical trial update reports termination of a Phase 1 safety study of XL844 in patients with Chronic Lymphocytic Leukemia and Small Ly…